Physician profile
Murray Adrian Cotter
NPI 1669598744
$3,898.32
in general payments reported to CMS, 2019-2025
17 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $103 · 2021: $358 · 2022: $131 · 2023: $579 · 2024: $2,046 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,922 · Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,921.50 |
| Food and Beverage | $942.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,966.15 | 2022-2024 | Libtayo, Dupixent |
| Abbvie INC. | $563.44 | 2019-2025 | Skyrizi |
| Novartis Pharmaceuticals Corporation | $463.20 | 2019-2025 | |
| Hill Dermaceuticals, INC. | $347.07 | 2023 | Tolak |
| Allergan, INC. | $123.49 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $115.06 | 2021 | |
| Prugen, INC. Pharmaceuticals | $71.28 | 2019-2020 | |
| Genzyme Corporation | $66.49 | 2019-2022 | |
| Janssen Biotech, INC. | $31.78 | 2019-2023 | Stelara, Simponi Aria, Simponi |
| Arcutis Biotherapeutics, INC. | $24.01 | 2023 | |
| Amgen INC. | $23.08 | 2019 | |
| Celgene Corporation | $21.72 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.13 | 2023 | Sotyktu |
| Mayne Pharma Commercial LLC | $17.37 | 2019 | |
| Kyowa Kirin, INC. | $17.29 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $15.98 | 2019 | |
| Lilly USA, LLC | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Cotter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.